Oxford BioDynamics Plc (AIM:OBD)
London · Delayed Price · Currency is GBP · Price in GBX 0.2500
0.00 (0.00%)
Mar 4, 2026, 3:37 PM GMT
Oxford BioDynamics Market Cap
Oxford BioDynamics has a market cap or net worth of 10.73 million as of March 4, 2026. Its market cap has increased by 24.79% in one year.
Market Cap
10.73M
Enterprise Value
14.45M
Revenue
1.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.25
Market Cap Chart
Since December 6, 2016, Oxford BioDynamics's market cap has decreased from 136.90M to 10.73M, a decrease of -92.16%. That is a compound annual growth rate of -24.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 10.73M | 16.28% |
| Dec 31, 2025 | 9.23M | 92.61% |
| Dec 31, 2024 | 4.79M | -91.54% |
| Dec 29, 2023 | 56.64M | 125.13% |
| Dec 30, 2022 | 25.16M | -34.45% |
| Dec 31, 2021 | 38.38M | -50.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 6, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptamer Group | 23.60M |
| SkinBioTherapeutics | 20.73M |
| Sareum Holdings | 20.71M |
| Fusion Antibodies | 17.50M |
| Genflow Biosciences | 9.87M |
| CRISM Therapeutics | 7.11M |
| IXICO | 7.07M |
| Futura Medical | 6.89M |